What are the risks of bone marrow transplantation

Update Date: Source: Network

summary

Some time ago, the body always felt dizzy, often listless, and always felt powerless. Later, I went to the hospital for examination, and found that I had leukemia, which was quite serious, and needed bone marrow transplantation. Now let's share the risks of bone marrow transplantation.

What are the risks of bone marrow transplantation

First, the success rate of bone marrow transplantation is tested by many factors and time. Generally, it has to go through five passes: 1. Chemotherapy before transplantation. 2, transplantation 3, immune rejection after transplantation. 4. Infection 5. Chemotherapy after transplantation. Only by successfully passing the above five levels in turn, and doing gene examination half a year later, we can find the gene expression of the donor in the patient's body, and the bone marrow, blood and important organs are normal without obvious symptoms.

Second, it is common in clinic that some patients relapse one month, three months, six months or even one year after transplantation. This is closely related to the patient's disease type, organ function, autoimmune reaction, complications during transplantation, the matching rate of gene loci between donor and patient, and the comprehensive level of transplantation hospital.

Third: bone marrow transplantation generally does not have any risk, but the success rate of surgery depends on the primary disease, some types of leukemia, bone marrow transplantation effect is very good, there is the possibility of radical cure, some effect is not good. After successful bone marrow transplantation, there is no need to take medicine to maintain life.

matters needing attention

The nursing work after bone marrow transplantation is very important. It not only needs the patients to do well consciously and keep a good attitude, but also needs the patients' family members to understand it clearly, so as to avoid any mistakes and affect the effect of the whole operation.